| Synonyms: | |
| Status: | Approved (1985) |
| Entry Type: | Small molecule |
| Molecule Category: | Parent |
| ATC: | C01BD01 |
| UNII: | N3RQ532IUT |
| InChI Key | IYIKLHRQXLHMJQ-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C25H29I2NO3 |
| Molecular Weight | 645.32 |
| AlogP | 6.94 |
| Hydrogen Bond Acceptor | 4.0 |
| Hydrogen Bond Donor | 0.0 |
| Number of Rotational Bond | 11.0 |
| Polar Surface Area | 42.68 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 3.0 |
| Heavy Atoms | 31.0 |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Arrhythmias, Cardiac | 4 | D001145 | ClinicalTrials |
| Heart Failure | 3 | D006333 | ClinicalTrials |
| Heart Failure | 3 | D006333 | ClinicalTrials |
| Atrial Flutter | 3 | D001282 | ClinicalTrials |
| Death, Sudden, Cardiac | 3 | D016757 | ClinicalTrials |
| Ventricular Fibrillation | 3 | D014693 | ClinicalTrials |
| Tachycardia, Ventricular | 3 | D017180 | ClinicalTrials |
| Atrial Fibrillation | 3 | D001281 | ClinicalTrials |
| Cardiomyopathies | 3 | D009202 | ClinicalTrials |
| Myocardial Infarction | 3 | D009203 | ClinicalTrials |
| Heart Arrest | 3 | D006323 | ClinicalTrials |
| Severe Acute Respiratory Syndrome | 2 | D045169 | ClinicalTrials |
| Tachycardia, Supraventricular | 2 | D013617 | ClinicalTrials |
| Hemorrhagic Fever, Ebola | 2 | D019142 | ClinicalTrials |
| Amyloidosis, Familial | 2 | D028226 | ClinicalTrials |
| Coronary Disease | 0 | D003327 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 1951-25-3 |
| ChEBI | 2663 |
| ChEMBL | CHEMBL633 |
| DrugBank | DB01118 |
| DrugCentral | 176 |
| EPA CompTox | DTXSID7022592 |
| FDA SRS | N3RQ532IUT |
| Human Metabolome Database | HMDB0015250 |
| Guide to Pharmacology | 2566 |
| KEGG | C06823 |
| PDB | BBI |
| PharmGKB | PA448383 |
| PubChem | 2157 |
| SureChEMBL | SCHEMBL16284 |
| ZINC | ZINC000003830212 |